Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus Severity
- 1 November 1998
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 102 (5) , e56
- https://doi.org/10.1542/peds.102.5.e56
Abstract
Objective. To evaluate neurodevelopmental outcome until 2 years of age in children who participated in a multicenter antenatal thyrotropin-releasing hormone (TRH) trial to improve respiratory outcome and to lower mortality.Keywords
This publication has 9 references indexed in Scilit:
- Ductus Arteriosus in Premature Infants Beyond the Second Week of LifePediatric Cardiology, 1997
- The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational ageAmerican Journal of Obstetrics and Gynecology, 1997
- Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacinThe Journal of Pediatrics, 1995
- Continuous Versus Multiple Rapid Infusions of Indomethacin: Effects on Cerebral Blood Flow VelocityPediatrics, 1995
- Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm laborThe Journal of Pediatrics, 1994
- Neonatal Complications after the Administration of Indomethacin for Preterm LaborNew England Journal of Medicine, 1993
- Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin useAmerican Journal of Obstetrics and Gynecology, 1993
- Persistent responsiveness of the neonatal ductus arteriosus in immature lambs: a possible cause for reopening of patent ductus arteriosus after indomethacin-induced closure.Circulation, 1985
- The ductus arteriosus in the preterm infant: Histologic and clinical observationsThe Journal of Pediatrics, 1980